Furthermore, mutations in other parts of embB (e.g. codon 406) [15] and upstream of embA [15, 16] and in embC [16, 17] are also involved in EMB resistance. Resistance to pyrazinamide (PZA) is known to be mediated by mutations occurring throughout the pncA gene, encoding a pyrazinamidase [18]. Resistant strains lack pyrazinamidase activity which is essential for pro drug activation. Since the frequency and combination of resistance mutations SAHA HDAC cost differs depending on the geographical setting in which the specific isolate is found [19, 20], it is important to analyze Mycobacterium tuberculosis

selleck compound complex (MTBC) strains from different regions and to determine putative setting specific molecular markers. However, up to now data about the accuracy of molecular diagnostic methods in high-incidence settings, and especially in West Africa, is only sparely available.

Therefore we carried out a population based study, involving MTBC strains from Sierra Leone, to determine the genetic basis of first line drug resistance and to compare results from molecular and conventional drug susceptibility testing. Methods Mycobacterial strains and growth conditions A total of 97 MTBC strains isolated from previously treated patients in Sierra Leone were included in this study. All smear positive cases registered for re-treatment (failure after at least 5 months, relapses or treatment after interruption) between March Akt inhibitor 2003 and June 2004 in the Western Area and Kenema districts in Sierra Leone were recruited. From the strains analyzed 50 were resistant to at least one of the following drugs 4-Aminobutyrate aminotransferase INH, RIF, SM, EMB and PZA and 47 strains were fully susceptible (see Figure 1). From the panel of strains analyzed, 74 were M. tuberculosis

and 23 were M. africanum strains. Primary isolation and cultivation was done at the Supranational Reference Laboratory in Borstel as described previously [21]. Figure 1 Overview of the antibiotic resistance profiles of the strains analyzed. A total of 97 M. tuberculosis and M. africanum strains from smear positive, previously treated patients from Sierra Leone was included in this study. Samples were collected in 2003 and 2004 in the Western Area and Kenema districts. Of the strains analyzed 74 were M. tuberculosis and 23 were M. africanum strains. Abbreviations: INH, isoniazid; RIF, rifampin; SM, streptomycin; EMB, ethambutol; PZA, pyrazinamide; R, resistance. Drug susceptibility testing Drug susceptibility testing (DST) to first-line drugs INH (0.25 and 1.0 μg/ml), RIF (20.0 and 40.0 μg/ml), SM (4.0 and 8.0 μg/ml) and EMB (1.0 and 2.0 μg/ml) was performed in Borstel by using the proportion method on Löwenstein-Jensen (LJ) medium.